Drugs with this side effect as MedDRA Preferred Term
- Abarelix
- Serum triglycerides increased
- Enfuvirtide
- Hypertriglyceridaemia: 1.9% - 2%
- Blood triglycerides increased: 1.9% - 2.9%
- FTY720
- Blood triglycerides increased: common, 3%
- K779
- Hypertriglyceridaemia: postmarketing
- LMWH
- Hypertriglyceridaemia: postmarketing
- PGE1
- Saxagliptin
- Zyprexa Relprevv
- abacavir
- abiraterone
- Hypertriglyceridaemia: 0% - 62.5%
- acitretin
- Hypertriglyceridaemia: 65%
- amprenavir
- Hypertriglyceridaemia: common, 40% - 56%
- aripiprazole
- Hypertriglyceridaemia
- Blood triglycerides increased
- asenapine
- atazanavir
- bazedoxifene
- Blood triglycerides increased: common
- bexarotene
- bisoprolol
- Serum triglycerides increased
- boceprevir
- Hypertriglyceridaemia: common
- candesartan
- candesartan cilexetil
- capecitabine
- Hypertriglyceridaemia: 0.1%
- carbamazepine
- Blood triglycerides increased: very rare
- carvedilol
- Hypertriglyceridaemia: 1%
- ceftobiprole
- Blood triglycerides increased
- cevimeline
- clevidipine
- Blood triglycerides increased: postmarketing
- clomiphene citrate
- Hypertriglyceridaemia: postmarketing
- clozapine
- Hypertriglyceridaemia: postmarketing
- colesevelam
- Hypertriglyceridaemia: postmarketing
- Serum triglycerides increased: common
- colestimide
- Hypertriglyceridaemia: uncommon
- darunavir
- Hypertriglyceridaemia: 1.53% - 3.23%
- Blood triglycerides increased: 0.612% - 3.05%
- delamanid
- delavirdine
- desvenlafaxine
- Blood triglycerides increased
- duloxetine
- Hypertriglyceridaemia: rare, infrequent
- efavirenz
- Hypertriglyceridaemia: postmarketing, common
- emtricitabine
- Hypertriglyceridaemia: postmarketing, common
- eplerenone
- Hypertriglyceridaemia: uncommon, 1%
- Serum triglycerides increased
- eprosartan
- Hypertriglyceridaemia: 1%
- etravirine
- everolimus
- Hypertriglyceridaemia: common, 0% - 52%
- Blood triglycerides increased
- febuxostat
- fluconazole
- Hypertriglyceridaemia: postmarketing
- fosamprenavir
- Hypertriglyceridaemia: common
- Blood triglycerides increased
- furosemide
- Blood triglycerides increased: very common
- gliclazide
- indinavir
- Hypertriglyceridaemia
- Serum triglycerides increased: postmarketing
- itraconazole
- Hypertriglyceridaemia: postmarketing, 3%
- ketoconazole
- lamivudine
- lasofoxifene
- Hypertriglyceridaemia: rare
- Blood triglycerides increased: rare
- lercanidipine
- linagliptin
- Hypertriglyceridaemia
- Blood triglycerides increased
- melatonin
- metoprolol
- Blood triglycerides increased: postmarketing
- mifepristone
- Blood triglycerides increased
- mirtazapine
- mitotane
- Hypertriglyceridaemia
- Blood triglycerides increased
- Plasma triglycerides increased
- moxifloxacin
- Blood triglycerides increased
- nadolol
- nelfinavir
- nevirapine
- nilotinib
- Hypertriglyceridaemia: common
- olanzapine
- Hypertriglyceridaemia: postmarketing
- olmesartan
- Hypertriglyceridaemia: uncommon, 2.05% - 2.12%
- olmesartan medoxomil
- paliperidone
- Hypertriglyceridaemia
- Blood triglycerides increased
- pantoprazole
- Hypertriglyceridaemia: very rare, postmarketing
- Blood triglycerides increased
- perhexiline
- ponatinib
- posaconazole
- pramipexole
- Blood triglycerides increased
- prednisolone phosphate
- prednisone
- propafenone
- Blood triglycerides increased
- raltegravir
- Blood triglycerides increased
- rapamycin
- Hypertriglyceridaemia: postmarketing, very common, 45% - 57%
- Serum triglycerides increased
- retinoic acid
- Hypertriglyceridaemia: postmarketing
- Blood triglycerides increased
- ribavirin
- Hypertriglyceridaemia: uncommon, common
- risperidone
- Hypertriglyceridaemia: rare
- Blood triglycerides increased: postmarketing
- ritonavir
- rosiglitazone
- saquinavir
- Hypertriglyceridaemia: postmarketing
- Blood triglycerides increased: very common
- stavudine
- tacrolimus
- Hypertriglyceridaemia: common, 65% - 65.4%
- tamoxifen
- tazarotene
- temsirolimus
- tenofovir disoproxil fumarate
- Hypertriglyceridaemia: postmarketing
- testosterone
- Hypertriglyceridaemia: postmarketing
- Blood triglycerides increased: postmarketing
- testosterone undecanoate
- Blood triglycerides increased
- tipranavir
- Hypertriglyceridaemia: common, 2%
- Blood triglycerides increased
- tramadol
- Hypertriglyceridaemia: postmarketing, uncommon
- triamcinolone acetonide
- v 1784
- Hypertriglyceridaemia: postmarketing
- Serum triglycerides increased: postmarketing
|